Prakt. lékáren. 2011; 7(1): 25-29

New medicinal substances in extemporaneous prescription, part 6 - triamcinolone acetonide

PharmDr.Zbyněk Sklenář, Ph.D.1,2, PharmDr.Jan Hašek3
1 Vyšší odborná škola zdravotnická, Plzeň
2 Lékárna Na Rohožníku, Praha
3 Lékárna U Matky Boží, Doksy

Triamcinolone acetonide is a synthetic fluorinated corticosteroid, a well-known drug in clinical practice. It has been available since November

2010 as a pharmaceutical substance, so the number of corticosteroids used for extemporaneous preparation in pharmacies has

increased. This article provides information on the properties and use of this substance applied mainly in dermatology, shows the options

of incorporating and presents examples of formulas suitable for magistral preparation. There is a possibility of extemporaneous

preparation in the case of outage of production of proprietary medicinal products contaning triamcinolone acetonide.

Keywords: triamcinolone-acetonide, corticosteroids, magistral preparation, muco-adhesive paste, triamcinolone acetonide stability

Published: February 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sklenář Z, Hašek J. New medicinal substances in extemporaneous prescription, part 6 - triamcinolone acetonide. Praktické lékárenství. 2011;7(1):25-29.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Štork J, et al. Dermatovenerologie. 1. vyd. Praha: Galén a Karolinum, 2008: 502 s.
    2. Benáková N. Ekzémy a dermatitidy. 1. vyd. Praha: Maxdorf, 2006: 125 s.
    3. Sklenář Z. Magistraliter receptura v dermatologii. 1. vyd. Praha: Galén 2009: 441 s.
    4. Mikro-verze AISLP - Automatizovaný informační systém léčivých přípravků. [CD-ROM]. Ver. ČR 2010.2 pro MS Windows platná k 1. 4. 2010. Praha, 2010.
    5. Kolektiv autorů. Remedia Compendium. 4.,přeprac. a rozšíř. vyd. Praha: Panax Co, s. r. o, 2009: 946 s.
    6. Deutscher Arzneimittel-Codex (DAC) 2007/Neues Rezeptur-Formularium (NRF). Band I-III. Pharmazeutischen Laboratorium des NRF. Eschborn: Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2007.
    7. Borovanský A, Csöllei J. Farmaceutická chemie (Farmakochemie) VII. Léčiva s účinkem na endokrinní systém (hormony). 1. vyd. Brno: VFU Brno, 2007: 177 s.
    8. Wynn, RL, Meiller, TF, Crossley, HL. Drug information handbook for dentistry. 15th ed. Ohio: Lexi-Comp, 2009: 2223 p.
    9. Viktorinová M. Přehled lokálních kortikosteroidů v dermatologii 1. Možnosti léčby kožních chorob kortikosteroidními externy. Klin Farmakol Farm 2006; 20(4): 202-210.
    10. Stüttgen G. Místní a systémová léčba z farmakokinetického hlediska. Čs Derm 1987; 62: 68-76.
    11. Peuke C, Dreeke-Ehrlich M. Rezeptur Leitlinien für die rationale Herstellung. Stuttgart: Deutscher Apotheker Verlag Stuttgart, 2005: 282-284.
    12. http://www.pharmazeutische-zeitung.de/fileadmin/nrf/PDF/1-Triamcinolonacetonid_Haut.pdf (datum náhledu: 30. 12. 2010).
    13. Komárek P, Rabišková M, et al. Technologie léků. 3. přeprac. a dopl. vyd. Praha: Galén, 2006: 157 s.
    14. Hašek J. Nové léčivé látky v magistraliter receptuře II - Dexpanthenol. Prakt Lékáren 2010; 6(4): 192-197.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.